TEST BANK FOR
Pharmacology and the Nursing Process 8th Edition
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
Contents
Chapter 01: The Nursing Process and Drug Therapy ..................................................................................... 4
Chapter 02: Pharmacologic Principles ........................................................................................................... 8
Chapter 03: Lifespan Considerations ........................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations .............................................................................. 20
Chapter 05: Medication Errors: Preventing and Responding ...................................................................... 26
Chapter 06: Patient Education and Drug Therapy ....................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements .............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
Chapter 09: Photo Atlas of Drug Administration ......................................................................................... 41
Chapter 10: Analgesic Drugs ........................................................................................................................ 50
Chapter 11: General and Local Anesthetics................................................................................................. 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................. 61
Chapter 13: Central Nervous System Stimulants and Related Drugs .......................................................... 66
Chapter 14: Antiepileptic Drugs .................................................................................................................. 70
Chapter 15: Antiparkinson Drugs ................................................................................................................ 76
Chapter 16: Psychotherapeutic Drugs ......................................................................................................... 81
Chapter 17: Substance Abuse ...................................................................................................................... 88
Chapter 18: Adrenergic Drugs ..................................................................................................................... 93
Chapter 19: Adrenergic-Blocking Drugs....................................................................................................... 98
Chapter 20: Cholinergic Drugs ................................................................................................................... 103
Chapter 21: Cholinergic-Blocking Drugs .................................................................................................... 108
Chapter 22: Antihypertensive Drugs ......................................................................................................... 113
Chapter 23: Antianginal Drugs .................................................................................................................. 119
Chapter 24: Heart Failure Drugs ................................................................................................................ 125
Chapter 25: Antidysrhythmic Drugs .......................................................................................................... 131
Med C
, Chapter 26: Coagulation Modifier Drugs ................................................................................................... 137
Chapter 27: Antilipemic Drugs .................................................................................................................. 143
Chapter 28: Diuretic Drugs ........................................................................................................................ 148
Chapter 29: Fluids and Electrolytes ........................................................................................................... 154
Chapter 30: Pituitary Drugs ....................................................................................................................... 160
Chapter 31: Thyroid and Antithyroid Drugs............................................................................................... 163
Chapter 32: Antidiabetic Drugs ................................................................................................................. 168
Chapter 33: Adrenal Drugs ........................................................................................................................ 177
Chapter 34: Women’s Health Drugs .......................................................................................................... 181
Chapter 35: Men’s Health Drugs ............................................................................................................... 188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants .......................................... 193
Chapter 37: Respiratory Drugs .................................................................................................................. 198
Chapter 38: Antibiotics Part 1 ................................................................................................................... 204
Chapter 39: Antibiotics Part 2 ................................................................................................................... 211
Chapter 40: Antiviral Drugs ....................................................................................................................... 216
Chapter 41: Antitubercular Drugs.............................................................................................................. 221
Chapter 42: Antifungal Drugs .................................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs............................................................ 231
Chapter 44: Anti-inflammatory and Antigout Drugs.................................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs....................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs .......... 248
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs....................................................... 253
Chapter 48: Immunosuppressant Drugs .................................................................................................... 258
Chapter 49: Immunizing Drugs .................................................................................................................. 263
Chapter 50: Acid-Controlling Drugs ........................................................................................................... 268
Chapter 51: Bowel Disorder Drugs ............................................................................................................ 274
Chapter 52: Antiemetic and Antinausea Drugs ......................................................................................... 281
Chapter 53: Vitamins and Minerals ........................................................................................................... 286
Chapter 54: Anemia Drugs ........................................................................................................................ 292
Chapter 55: Nutritional Supplements........................................................................................................ 299
Chapter 56: Dermatologic Drugs ............................................................................................................... 304
Med C
, Chapter 57: Ophthalmic Drugs .................................................................................................................. 310
Chapter 58: Otic Drugs .............................................................................................................................. 315
Med C
, Chapter 01: The Nursing Process and Drug Therapy
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
In een oud vissersdorp aan de Noordzee woonde een meisje
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
genaamd Lotte. Ze was dol op schelpen en verzamelde elke
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
dag nieuwe exemplaren op het strand. Op een mistige ochtend
diagnosis?
a. Anxiety vond ze een schelp die anders was dan alle andere: hij gloeide
zachtjes
b. Anxiety related to newblauw op. Toen ze hem tegen haar oor hield, hoorde
drug therapy
c. Anxiety related to anxious feelings een
ze niet de zee, maar aboutzachte stem die
drug therapy, fluisterde:by
as evidenced “Breng me
statements
such as “I’mnaar
upsethuis.”
aboutLotte
having volgde
to testhet
my geluid de hele dag. Ze liep over
blood sugars.”
duinen, door weilanden en langs smalle
d. Anxiety related to new drug therapy, as evidenced by statements paadjessuch tot ze bij een
as “I’m
upset about verborgen
having to testgrot
mykwam. Binnenin stond een oud altaar met
blood sugars.”
honderden schelpen. Ze legde de gloeiende schelp ertussen
ANS: D en plotseling begon de grot te stralen. Uit het licht verscheen
Formulation of nursing diagnoses isdie
een zeemeermin usually a three-step
zei: “Dank process.
je. Deze schelp “Anxiety”
was mijn is missing
stem. the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
Nu ben ik weer vrij.” Als dank gaf ze Lotte een kleine parel die
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
altijd warm bleef. Vanaf die dag vond Lotte nooit meer een
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
gewone schelp zonder glimlach. Ze wist dat de zee haar vriend
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
was en dat sommige wonderen alleen verschijnen aan wie echt
DIF: COGNITIVE luistert.
LEVEL:HetUnderstanding
dorp vertelde haar verhaal nog
(Comprehension) jaren
REF: p. 7 door.（199
woorden）
TOP: NURSING PROCESS: Nursing Diagnosis
MSC: NCLEX: Safe 4. Svenska (Swedish
and Effective – Scandinavian
Care Environment: language)
Management of Care
I en liten by vid en frusen sjö bodde en gammal man som het
2. The patient is toErik. Han
receive hade
oral en gammal
guaifenesin vedspis
(Mucinex) som
twice alltidToday,
a day. brann, theäven
nursenärwas busy and
veden tog slut. Varje kväll satt han där och berättade historier does this
gave the medication 2 hours after the scheduled dose was due. What type of problem
represent? för sin katt, Måne. En vinternatt hörde han ett knackande på
a. “Right time”
dörren. Utanför stod en liten flicka med röda kinder och frusna
b. “Right dose”
fingrar. Hon sa att hon hade gått vilse. Erik bjöd in henne, gav
c. “Right route”
henne varm choklad och lät henne sova i sin egen säng. Nästa
d. “Right medication”
morgon var flickan borta, men på bordet låg en liten snöflinga
ANS: A av glas som aldrig smälte. Erik hängde den i fönstret. Varje
gång solen
“Right time” is correct becausesken
thegenom denwas
medication skapades regnbågar
given more than 30 över
minutes helaafter the
scheduled dose rummet. Folk i byn började kalla hans hus för “regnbågshuset”.
was due. “Dose” is incorrect because the dose is not related to the time the
Åren gick,isoch
medication administration Erik blev
scheduled. äldre,ismen
“Route” snöflingan
incorrect because lyste alltid.isEn
the route not affected.
“Medication” isdagincorrect because the medication ordered will not change.
kom en vuxen kvinna till dörren. Det var flickan från den
vinternatten. Hon hade blivit läkare och ville tacka honom. Erik
DIF: COGNITIVE LEVEL: Applying (Application) REF: p. 11
log och sa: “Du var
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. Which phase of the
nursing process do these actions illustrate?
a. Nursing diagnosis
Med C
Pharmacology and the Nursing Process 8th Edition
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
Contents
Chapter 01: The Nursing Process and Drug Therapy ..................................................................................... 4
Chapter 02: Pharmacologic Principles ........................................................................................................... 8
Chapter 03: Lifespan Considerations ........................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations .............................................................................. 20
Chapter 05: Medication Errors: Preventing and Responding ...................................................................... 26
Chapter 06: Patient Education and Drug Therapy ....................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements .............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
Chapter 09: Photo Atlas of Drug Administration ......................................................................................... 41
Chapter 10: Analgesic Drugs ........................................................................................................................ 50
Chapter 11: General and Local Anesthetics................................................................................................. 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................. 61
Chapter 13: Central Nervous System Stimulants and Related Drugs .......................................................... 66
Chapter 14: Antiepileptic Drugs .................................................................................................................. 70
Chapter 15: Antiparkinson Drugs ................................................................................................................ 76
Chapter 16: Psychotherapeutic Drugs ......................................................................................................... 81
Chapter 17: Substance Abuse ...................................................................................................................... 88
Chapter 18: Adrenergic Drugs ..................................................................................................................... 93
Chapter 19: Adrenergic-Blocking Drugs....................................................................................................... 98
Chapter 20: Cholinergic Drugs ................................................................................................................... 103
Chapter 21: Cholinergic-Blocking Drugs .................................................................................................... 108
Chapter 22: Antihypertensive Drugs ......................................................................................................... 113
Chapter 23: Antianginal Drugs .................................................................................................................. 119
Chapter 24: Heart Failure Drugs ................................................................................................................ 125
Chapter 25: Antidysrhythmic Drugs .......................................................................................................... 131
Med C
, Chapter 26: Coagulation Modifier Drugs ................................................................................................... 137
Chapter 27: Antilipemic Drugs .................................................................................................................. 143
Chapter 28: Diuretic Drugs ........................................................................................................................ 148
Chapter 29: Fluids and Electrolytes ........................................................................................................... 154
Chapter 30: Pituitary Drugs ....................................................................................................................... 160
Chapter 31: Thyroid and Antithyroid Drugs............................................................................................... 163
Chapter 32: Antidiabetic Drugs ................................................................................................................. 168
Chapter 33: Adrenal Drugs ........................................................................................................................ 177
Chapter 34: Women’s Health Drugs .......................................................................................................... 181
Chapter 35: Men’s Health Drugs ............................................................................................................... 188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants .......................................... 193
Chapter 37: Respiratory Drugs .................................................................................................................. 198
Chapter 38: Antibiotics Part 1 ................................................................................................................... 204
Chapter 39: Antibiotics Part 2 ................................................................................................................... 211
Chapter 40: Antiviral Drugs ....................................................................................................................... 216
Chapter 41: Antitubercular Drugs.............................................................................................................. 221
Chapter 42: Antifungal Drugs .................................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs............................................................ 231
Chapter 44: Anti-inflammatory and Antigout Drugs.................................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs....................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs .......... 248
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs....................................................... 253
Chapter 48: Immunosuppressant Drugs .................................................................................................... 258
Chapter 49: Immunizing Drugs .................................................................................................................. 263
Chapter 50: Acid-Controlling Drugs ........................................................................................................... 268
Chapter 51: Bowel Disorder Drugs ............................................................................................................ 274
Chapter 52: Antiemetic and Antinausea Drugs ......................................................................................... 281
Chapter 53: Vitamins and Minerals ........................................................................................................... 286
Chapter 54: Anemia Drugs ........................................................................................................................ 292
Chapter 55: Nutritional Supplements........................................................................................................ 299
Chapter 56: Dermatologic Drugs ............................................................................................................... 304
Med C
, Chapter 57: Ophthalmic Drugs .................................................................................................................. 310
Chapter 58: Otic Drugs .............................................................................................................................. 315
Med C
, Chapter 01: The Nursing Process and Drug Therapy
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
In een oud vissersdorp aan de Noordzee woonde een meisje
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
genaamd Lotte. Ze was dol op schelpen en verzamelde elke
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
dag nieuwe exemplaren op het strand. Op een mistige ochtend
diagnosis?
a. Anxiety vond ze een schelp die anders was dan alle andere: hij gloeide
zachtjes
b. Anxiety related to newblauw op. Toen ze hem tegen haar oor hield, hoorde
drug therapy
c. Anxiety related to anxious feelings een
ze niet de zee, maar aboutzachte stem die
drug therapy, fluisterde:by
as evidenced “Breng me
statements
such as “I’mnaar
upsethuis.”
aboutLotte
having volgde
to testhet
my geluid de hele dag. Ze liep over
blood sugars.”
duinen, door weilanden en langs smalle
d. Anxiety related to new drug therapy, as evidenced by statements paadjessuch tot ze bij een
as “I’m
upset about verborgen
having to testgrot
mykwam. Binnenin stond een oud altaar met
blood sugars.”
honderden schelpen. Ze legde de gloeiende schelp ertussen
ANS: D en plotseling begon de grot te stralen. Uit het licht verscheen
Formulation of nursing diagnoses isdie
een zeemeermin usually a three-step
zei: “Dank process.
je. Deze schelp “Anxiety”
was mijn is missing
stem. the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
Nu ben ik weer vrij.” Als dank gaf ze Lotte een kleine parel die
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
altijd warm bleef. Vanaf die dag vond Lotte nooit meer een
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
gewone schelp zonder glimlach. Ze wist dat de zee haar vriend
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
was en dat sommige wonderen alleen verschijnen aan wie echt
DIF: COGNITIVE luistert.
LEVEL:HetUnderstanding
dorp vertelde haar verhaal nog
(Comprehension) jaren
REF: p. 7 door.（199
woorden）
TOP: NURSING PROCESS: Nursing Diagnosis
MSC: NCLEX: Safe 4. Svenska (Swedish
and Effective – Scandinavian
Care Environment: language)
Management of Care
I en liten by vid en frusen sjö bodde en gammal man som het
2. The patient is toErik. Han
receive hade
oral en gammal
guaifenesin vedspis
(Mucinex) som
twice alltidToday,
a day. brann, theäven
nursenärwas busy and
veden tog slut. Varje kväll satt han där och berättade historier does this
gave the medication 2 hours after the scheduled dose was due. What type of problem
represent? för sin katt, Måne. En vinternatt hörde han ett knackande på
a. “Right time”
dörren. Utanför stod en liten flicka med röda kinder och frusna
b. “Right dose”
fingrar. Hon sa att hon hade gått vilse. Erik bjöd in henne, gav
c. “Right route”
henne varm choklad och lät henne sova i sin egen säng. Nästa
d. “Right medication”
morgon var flickan borta, men på bordet låg en liten snöflinga
ANS: A av glas som aldrig smälte. Erik hängde den i fönstret. Varje
gång solen
“Right time” is correct becausesken
thegenom denwas
medication skapades regnbågar
given more than 30 över
minutes helaafter the
scheduled dose rummet. Folk i byn började kalla hans hus för “regnbågshuset”.
was due. “Dose” is incorrect because the dose is not related to the time the
Åren gick,isoch
medication administration Erik blev
scheduled. äldre,ismen
“Route” snöflingan
incorrect because lyste alltid.isEn
the route not affected.
“Medication” isdagincorrect because the medication ordered will not change.
kom en vuxen kvinna till dörren. Det var flickan från den
vinternatten. Hon hade blivit läkare och ville tacka honom. Erik
DIF: COGNITIVE LEVEL: Applying (Application) REF: p. 11
log och sa: “Du var
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. Which phase of the
nursing process do these actions illustrate?
a. Nursing diagnosis
Med C
